Viviana De Caro

Prof. Viviana De Caro

University of Palermo, Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2000 in NeuroReport
Verified
Journal Article
Closed access
GSGiovanni Savettieri
Giovanni Savettieri
Italia Di LiegroItalia Di Liegro
Italia Di Liegro
CCCaterina Catania
Caterina Catania
LLLuana Licata
Luana Licata
GPGiovanna Laura Pitarresi
Giovanna Laura Pitarresi
ACAlessandro Cestelli
Alessandro Cestelli
We report that extracellular matrix and neurons modulate the expression of occludin, one of the main components of tight junctions, by rat brain endothelial cells (RBE4.B). Of the three extracellular matrix proteins which we tested (collagen I, collagen IV, and laminin), collagen IV stimulated at the best the expression of occludin mRNA. The corresponding protein, however, was not synthesized. Significant amounts of occludin accumulated only when RBE4.B cells were cultured on collagen IV-coated inserts, in the presence of cortical neurons, plated on laminin-coated companion wells. Finally, occludin segregated at the cell periphery, only when endothelial cells were co-cultured with neurons for ≥ 1 week.

30 March 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
STSimona Taverna
Simona Taverna
Simona FontanaSimona Fontana
Simona Fontana
FMFrancesca Monteleone
Francesca Monteleone
MPMarzia Pucci
Marzia Pucci
LSLaura Saieva
Laura Saieva
Riccardo AlessandroRiccardo Alessandro
Riccardo Alessandro
Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype, via exosomal miR-21

19 December 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
Giulia Di PrimaGiulia Di Prima
Giulia Di Prima
EBElena Belfiore
Elena Belfiore
MMMartina Migliore
Martina Migliore
ASAmalia Giulia Scarpaci
Amalia Giulia Scarpaci
GAGiuseppe Angellotti
Giuseppe Angellotti
Viviana De CaroViviana De Caro
Viviana De Caro
In an ever-growing perspective of circular economy, the development of conscious, sustainable and environmental-friendly strategies to recycle the waste products is the key point. The scope of this work was to validate the waste bentonite from the grape processing industries as a precious matrix to extract polyphenols by applying a waste-to-market approach aimed at producing novel functional excipients. The waste bentonite was recovered after the fining process and opportunely pre-treated. Subsequently, both the freeze dried and the so-called “wet” bentonites were subjected to maceration. PEG200 and Propylene Glycol were selected as solvents due to their ability to dissolve polyphenols and their wide use in the cosmetic/pharmaceutical field. The extracts were evaluated in terms of yield, density, pH after water-dilution, total phenolic (Folin–Ciocalteu) and protein (Bradford) contents, antioxidant power (DPPH), amount of some representative polyphenols (HPLC-DAD), cytocompatibility and stability. Both solvents validated the bentonite as a valuable source of polyphenols and led to colored fluids characterized by an acidic pH after water-dilution. The best extract was obtained from the wet bentonite with PEG200 and highlighted the highest phenolic content and consequently the strongest antioxidant activity. Additionally, it displayed proliferative properties and resulted almost stable over time. Hence, it might be directly used as polyphenols-enriched functional novel raw material for cosmetic and pharmaceutics purposes.

1 September 2007 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
LGLibero Italo Giannola
Libero Italo Giannola
Viviana De CaroViviana De Caro
Viviana De Caro
GGGiulia Giandalia
Giulia Giandalia
MSMaria Gabriella Siragusa
Maria Gabriella Siragusa
CTClaudio Tripodo
Claudio Tripodo
Giuseppina CampisiGiuseppina Campisi
Giuseppina Campisi


13 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
GAGiuseppe Angellotti
Giuseppe Angellotti
Giulia Di PrimaGiulia Di Prima
Giulia Di Prima
EBElena Belfiore
Elena Belfiore
Giuseppina CampisiGiuseppina Campisi
Giuseppina Campisi
Viviana De CaroViviana De Caro
Viviana De Caro
Oral squamous cell carcinoma (OSCC) is one of the most prevailing and aggressive head and neck cancers, featuring high morbidity and mortality. The available conventional treatments suffer from several adverse effects and are often inefficient in terms of their survival rates. Thus, seeking novel therapeutic agents and adjuvants is of the utmost importance for modern society. Natural polyphenolic compounds have recently emerged as promising chemopreventive and anticancer agents. Specifically, the natural compound resveratrol (RSV) has recently gained momentum for this purpose. RSV is useful for treating OSCC due to its antiproliferative, antimetastatic, and proapoptotic effects. Additionally, RSV acts against tumor cells while synergically cooperating with chemotherapeutics, overcoming drug resistance phenomena. Despite these wide-spectrum effects, there are few specific investigations regarding RSV’s effects against OSCC animal models that consider different routes and vehicles for the administration of RSV. Interestingly, an injectable RSV-loaded liposome-based formulation was proven to be effective against both in vitro and in vivo OSCC models, demonstrating that the development of RSV-loaded drug delivery systems for systemic and/or loco-regional applications may be the turning point in oral cancer treatment, leading to benefits from both RSV’s properties as well as from targeted delivery. Given these premises, this review offers a comprehensive overview of the in vitro and in vivo effects of RSV and its main derivative, polydatin (PD), against OSCC-related cell lines and animal models, aiming to guide the scientific community in regard to RSV and PD use in the treatment of oral precancerous and cancerous lesions.